Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pay-for-delay
Pharma
Jury awards $885M in Takeda pay-for-delay antitrust case
Takeda plans to appeal after a jury found it liable in a landmark pay-for-delay antitrust case and ordered the Japanese drugmaker to pay $885 million.
Kevin Dunleavy
May 19, 2026 8:39am
Pfizer ponies up $39M to resolve old pay-for-delay lawsuit
Apr 11, 2024 11:00am
Another EpiPen antitrust settlement costs Pfizer $50M
Oct 11, 2023 6:03pm
Takeda settles antitrust lawsuit over gout drug Colcrys
Sep 21, 2023 10:55am
Gilead and Teva's HIV antitrust trial kicks off in California
May 25, 2023 9:20am
Merck, Glenmark settle part of Zetia pay-for-delay case
Apr 21, 2023 9:42am
